EcoDrugPlus

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSCDRG00005000707
Gene Symbol: F2R
3 Cross references
330 Possible Orthologues:

Coagulation Factor Ii, Thrombin

Ensembl ID : ENSCDRG00005009091
Gene Symbol: F2
1 Cross references
86 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSCDRG00005001755
Gene Symbol: F3
3 Cross references
246 Possible Orthologues:

Coagulation Factor Vii

Ensembl ID : ENSCDRG00005009648
Gene Symbol: F7
3 Cross references
203 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSCDRG00005009751
Gene Symbol: F10
3 Cross references
239 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSCDRG00005011714
Gene Symbol: F11
1 Cross references
215 Possible Orthologues:

Coagulation Factor Xii

Ensembl ID : ENSCDRG00005009012
Gene Symbol: F12
3 Cross references
187 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSCDRG00005012383
Gene Symbol: CCDC6
1 Cross references
223 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSCDRG00005002338
Gene Symbol: CSF1R
3 Cross references
273 Possible Orthologues:

Complement C1s

Ensembl ID : ENSCDRG00005019604
Gene Symbol: C1S
3 Cross references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSCDRG00005011738
Gene Symbol: C5
1 Cross references
212 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSCDRG00005021783
Gene Symbol: CRHR1
1 Cross references
208 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).